If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be ...

Gans, PharmD. APhA also has concerns about the designation of MDIs and DPIs as demonstrably difficult to compound based on FDA's conclusion that inhalers contain important drug substance ...